Phase 1 randomized controlled trial to evaluate the safety and immunogenicity of recombinant Pichia pastoris-expressed Plasmodium falciparum apical membrane antigen 1 (PfAMA1-FVO [25-545]) in healthy Malian adults in Bandiagara
在马里邦贾加拉开展的一项 1 期随机对照试验,旨在评估重组毕赤酵母表达的恶性疟原虫顶端膜抗原 1 (PfAMA1-FVO [25-545]) 在健康马里成年人中的安全性和免疫原性。
期刊:Malaria Journal
影响因子:3
doi:10.1186/s12936-016-1466-4
Thera, Mahamadou A; Coulibaly, Drissa; Kone, Abdoulaye K; Guindo, Ando B; Traore, Karim; Sall, Abdourhamane H; Diarra, Issa; Daou, Modibo; Traore, Idrissa M; Tolo, Youssouf; Sissoko, Mady; Niangaly, Amadou; Arama, Charles; Baby, Mounirou; Kouriba, Bourema; Sissoko, Mahamadou S; Sagara, Issaka; Toure, Ousmane B; Dolo, Amagana; Diallo, Dapa A; Remarque, Edmond; Chilengi, Roma; Noor, Ramadhani; Sesay, Sanie; Thomas, Alan; Kocken, Clemens H; Faber, Bart W; Imoukhuede, Egeruan Babatunde; Leroy, Odile; Doumbo, Ogobara K